Skip to main content

Table 2 Inclusion and exclusion criteria

From: Design and rationale of a large, international, prospective cohort study to evaluate the occurrence of malformations and perinatal/neonatal death using insulin detemir in pregnant women with diabetes in comparison with other long-acting insulins

Inclusion criteria
• Woman with a positive pregnancy test
• Type 1 diabetes or type 2 diabetes, diagnosed prior to conception
• Treated with unchanged basal insulin or other injectable antidiabetic treatment (for those not treated with basal insulin) for 4 weeks prior to and following conception
• Informed consent obtained before any data collection
Exclusion criteria
• Women who have been pregnant for >12 weeks at baseline visit confirmed by ultrasound